Front page news
While many are aware of Dr. Bertone’s excellence as a highly successful and productive scientist, educator, and veterinary clinician/surgeon, fewer are aware of her contributions to enhance gender equality and faculty advancement.
1. Thanks to dialysis, Phoebe the cat survives lily poisoning
When Phoebe, a 23-month-old cat from Missouri, took a few nibbles of a lily plant, her owners didn’t think a thing. Unfortunately neither Phoebe nor her owners were aware of the dire consequences that would ensue.
A short survey to assess veterinarians' knowledge and practices related to Harmful Algal Blooms commonly known as blue-green algae toxicosis in animals.
Emerging infectious diseases represent major threats to global security, economic development, and human and animal health. Over 70% of emerging infectious diseases today are zoonotic, and developing regions, particularly sub-Saharan Africa, are recognized as hotspots of newly emerging zoonotic microbes and multi-drug resistant bacteria. Dr.
Columbus, OH - The Petco Foundation and Blue Buffalo Foundation announced grant investments totaling $350,000 to support pet cancer research and treatment initiatives for Blue Buffalo Veterinary Clinical Trials at The Ohio State University College of Veterinary Medicine.
From a cancer diagnosis to a remarkable recovery to his final days, Marley the chocolate lab never failed to make an impact on those around him. When Marley received exceptional care from Ohio State, his owners decided to show their gratitude.
From June 27 to July 1, select high school students ventured to The Ohio State University for Buckeye Vet Prep Academy, hosted by the College of Veterinary Medicine, to be educated on the diverse career paths in veterinary medicine.
As part of the Summer Research Program, veterinary student Balbine Jourdan is working in Ethiopia to study the role of wildlife in circulating multi-drug resistant salmonella across space and species, which is currently unknown.
Dr. Jianrong Li, Department of Veterinary Biosciences, and his research team have received a five-year, $3.1 million grant from the National Institute of Allergy and Infectious Disease to continue their work on developing a vaccine for human norovirus.
Dr. Wondwossen Gebreyes, professor and director of global health programs, was named a recipient of Universitas 21 (U21) Award for Internationalization, which he formally received on May 12 at the National University of Singapore.